Health
GenScript and Selecxine Enter Into Strategic Cooperation Agreement
SEOUL, South Korea, Dec. 26, 2019 /PRNewswire/ -- On Dec. 23, 2019, at Seoul, South Korea, the CDMO segment of the world's leading biotech company GenScript announced that it signed a strategic collaboration agreement with Selecxine Inc., a Korean biotech company dedicated to novel therapeutics f...
2019-12-26 22:00
10940
The 13th Dongzhi Ejiao Festival Held in Dong'e County, Shandong Province
DONG'E, China, Dec. 26, 2019 /PRNewswire/ -- On December 22, the 13th Dongzhi Ejiao Festival was held in Ejiao's birthplace, Dong'e County,Shandong Province. It was sponsored by the Herbal Paste Branch of the China Association of Chinese Medicine, the Ejiao Specialty Committee of the China Associ...
2019-12-26 17:51
1529
ALS Awareness Project Led by an ALS Patient
TOKYO, Dec. 24, 2019 /PRNewswire/ -- The END ALS Association (Representative: Motoi Ito, Tokyo, Japan) announced the launch of their Merry & Bright - EEG Illumination project. The objective of this project is to enable Masahiro "Hiro" Fujita,an ALS patient and founder of the association, who has ...
2019-12-24 21:49
1725
Viva Biotech Awarded 'Top 10 Public Companies'
BEIJING, Dec. 24, 2019 /PRNewswire/ -- The 'Future Healthcare VB 100 Summit' organized by VCBeat and VCBeat Research was held inBeijing. Viva Biotech was invited to the Summit and awarded the 'Top 10 Public Companies 2019' with honor. Dr. David Xu, the Chief Business Officer of Viva Biotech, was ...
2019-12-24 18:18
1440
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
Demonstrates Evoke® ECAP-Controlled Closed-Loop SCS Provides Statistically Superior Pain Relief Compared to Open-Loop SCS ARTARMON, Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announcedThe Lancet Neurology journal published results from the U.S. P...
2019-12-21 07:48
1703
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation
ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...
2019-12-20 22:00
12875
HISKY, a leader in the innovative detection technology of liver health, launches the new brand iLivTouch
BEIJING, Dec. 20, 2019 /PRNewswire/ -- Recently, Wuxi Hisky Medical Technologies Co., Ltd. (hereinafter referred to as "HISKY") has successfully launched its new brand iLivTouch based on the MigTE technology. "On the increasingly competitive market, cycles of technological innovation are key to ...
2019-12-20 15:49
933
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC
SEONGNAM, South Korea, Dec. 19, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company filed an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) and the Ministry...
2019-12-20 10:19
1241
Shenzhen signs projects worth RMB 560 billion as it promotes investment globally
SHENZHEN, China, Dec. 19, 2019 /PRNewswire/ -- Shenzhen Global Investment Promotion Conference 2019, hosted by the People's Government of Shenzhen and organized by such government entities as the Development and Reform Commission of Shenzhen Municipality, was held in the southern Chinese city on ...
2019-12-19 21:11
1895
Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug
SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed an exclusive license deal with US-based Onconova Therapeutics (NASDAQ: ONTX), securing commercialisation rights to a new therapy for the treatment of Myelodysplastic Syndrome...
2019-12-18 22:00
2737
Dr. Jie Jack Li joins Shanghai ChemPartner as a Vice President of Discovery Chemistry
SHANGHAI, Dec. 17, 2019 /PRNewswire/ -- Shanghai ChemPartner announced the appointment ofJie Jack Li, Ph.D. as a Vice President of Discovery Chemistry at the Company headquarters inShanghai, China. Dr. Li is an established chemist with over 20 years of experience in both medicinal chemistry and ...
2019-12-18 00:00
1922
TransThera Biosciences Announces IND Approval from FDA for Clinical Studies of TT-00920 to Treat Chronic Heart Failure
NANJING, China, Dec. 16, 2019 /PRNewswire/ -- TransThera Biosciences Co. Ltd, a clinical-stage biotechnology company based inNanjing, China, announced today that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for TT-00920, a novel ...
2019-12-17 08:00
1397
VolitionRx Limited Announces Strategic Acquisition
AUSTIN, Texas, Dec. 16, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced an agreement by its subsidiary Belgian Volition SPRL to acquire an epigenetic reagent company, Octamer GmbH ("Octamer"), for approximately$725,000 consisting of cash and shares of r...
2019-12-16 21:30
13834
Senhwa Biosciences Reports Positive Phase 1 Data of CX-5461 in Patients With Advanced Solid Tumors at 2019 SABCS
TAIPEI and SAN DIEGO, Dec. 12, 2019 /PRNewswire/ -- Senhwa Biosciences Inc. (TPEx: 6492), a clinical stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced positive results from its Phase 1 trial of CX-5461. C...
2019-12-13 04:00
2186
United Imaging's Artificial Intelligence Subsidiary Wins in Facebook AI Research & NYU School of Medicine Global Competition
HOUSTON, Dec. 12, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, followed a strong appearance at the annual meeting of the Radiological Society ofNorth America (RSNA) with a win in a competition jointly organized by Facebook AI Researc...
2019-12-12 21:00
1618
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA
SINGAPORE, Dec. 11, 2019 /PRNewswire/ -- Specialty pharmaceutical company iX Biopharma Ltd(SGX:42C) ("iX Biopharma" or, "the Company") is pleased to announce that it has successfully concluded an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding Wafermine, a sublin...
2019-12-11 22:00
1902
Breakthrough in Medical Electronics - A Novel Mixed & Augmented Reality Smart Glasses Surgical Navigation Solution
TAICHUNG, Dec. 10, 2019 /PRNewswire/ -- The mixed reality technology for surgery usually shown in the movies has now become a reality with the latest technological offering from theTaiwan-based company – Taiwan Main Orthopaedics Biotechnology and the branding name of medical devices is SURGLAS...
2019-12-10 16:34
877
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies
SUZHOU, China and SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd ("Gracell"), a clinical-stage immune cell therapy company, today announced the progressive clinical outcomes for leading product candidates FasTCAR-19, Dual CAR-19-22, and Dual CAR-BCMA-19 at the American...
2019-12-09 22:00
1347
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors
HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the
'company') today announced that the first patient was successfully dosed on
December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001
program at NEXT ONCOLOGY inSan Antonio, Texas.
2019-12-09 21:00
1403
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody
SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company committed to discovering and developing a combined platform of Chimeric Antigen Receptor T (CAR-T) cell therapies and monoclonal antibodies for cancer, today announced that one of its leading d...
2019-12-09 18:00
3105
Week's Top Stories
Most Reposted
Singapore-based video streaming provider teams up with renowned celebrity platform to provide much-needed boost for brands
[Picked up by 318 media titles]
2024-09-13 17:12
HS HYOSUNG Unveils New CI and Vision, Embracing "Star" and "Tree" Symbolism
[Picked up by 313 media titles]
2024-09-11 20:27VinCSS, A Vietnamese Startup, Becomes the World's First Company to Secure FIDO Device Onboarding (FDO) Certificates
[Picked up by 298 media titles]
2024-09-11 15:20
NATIONAL ENERGY AWARDS 2024 SHOWCASES MALAYSIA'S COMMITMENT TO ENERGY MANAGEMENT, ENERGY EFFICIENCY AND RENEWABLE ENERGY SOLUTIONS
[Picked up by 282 media titles]
2024-09-13 15:00
MELISHA LIN CROWNED MISS GRAND MALAYSIA 2024
[Picked up by 267 media titles]
2024-09-13 17:20
Most Read
VinCSS, A Vietnamese Startup, Becomes the World's First Company to Secure FIDO Device Onboarding (FDO) Certificates
2024-09-11 15:20
6008
HS HYOSUNG Unveils New CI and Vision, Embracing "Star" and "Tree" Symbolism
2024-09-11 20:27
5651
Mushiny Establishes Subsidiary in Japan and Showcases New Products at LTT Expo Empowering Local Partners: Mushiny's Deep Collaboration to Revolutionize the Future of Logistics
2024-09-10 17:12
5207
Circles and e& international mark one-year success of JV & digital telco leadership
2024-09-10 15:00
4701
InCorp Global Wins "Sustainability Champion" Award at PrimeGlobal's Golden Globes
2024-09-10 17:00
4686